Equity Profile

XRAY

DENTSPLY SIRONA Inc.

Health CareHealth Care Supplies$2.3B

Aug6Thu

Pre-Earnings Brief

UpcomingQ2-2026After Close5:00 PM EDT

Company Snapshot

DENTSPLY SIRONA Inc. (XRAY) is a leading manufacturer of dental products and technologies, operating in the Health Care Supplies sector....

Key Metrics to Watch

Earnings Per Share (EPS)

EPS is a key indicator of the company's profitability and financial health, which investors closely monitor.

N/A

Revenue Growth

Revenue growth reflects the company's ability to expand its market presence and sales, which is vital for long-term success.

N/A

1 more metrics, Wall Street expectations, options signals, track record, and call prep available with Pro.

XRAY Q2-2026 Earnings Preview

Context

Company Snapshot

DENTSPLY SIRONA Inc. (XRAY) is a leading manufacturer of dental products and technologies, operating in the Health Care Supplies sector. The company plays a crucial role in providing innovative solutions for dental professionals, which is important as the demand for dental care continues to grow globally.

Earnings Scorecard·Last 8Q

EPS Beat Streak

EPS Beat Rate

38%

Avg EPS Surprise

-1.32%

Avg Stock Reaction

-4.29%

Last Quarter Recap

In Q1-2026, DENTSPLY SIRONA reported an EPS of $0.27, slightly missing estimates. The stock reacted positively, gaining 1.52% the following day.

Management Promises & Guidance

Expectations

Wall Street Expectations

Overall, expectations for DENTSPLY SIRONA's upcoming earnings are cautious, given recent earnings misses. Investors are looking for signs of improvement in profitability and revenue growth.

Bull Case

If DENTSPLY SIRONA can exceed EPS expectations and show strong revenue growth, it could signal a turnaround and boost investor confidence.

Bear Case

Conversely, if the company continues to miss earnings estimates and fails to provide strong guidance, it may lead to further declines in stock price.

Expectations

Two Questions That Matter

The print will turn on these two things.

What will the EPS be for Q2-2026?

EPS is a critical measure of profitability, and a significant deviation from expectations could impact investor sentiment.

How does management plan to address recent revenue growth challenges?

Investors will be keen to hear strategies for improving sales, which is essential for the company's recovery and future growth.

Edge

What the Street Is Missing

Why consensus could be wrong

The market may be underestimating DENTSPLY SIRONA's potential for a turnaround, as recent earnings misses do not fully account for the company's ongoing investments in product innovation.

Supporting Evidence

Options are pricing an 8.69% move, indicating that traders expect significant volatility, which could reflect underlying opportunities.

Despite recent misses, the company's historical performance shows potential for recovery if management can effectively communicate their strategy.

Key Risk

If the EPS comes in above $0.30, it could challenge the bearish sentiment and shift market expectations.

Edge

Thesis-Break Levels

Pre-commit to what would confirm each case.

This quarter's performance is critical as the company has struggled with earnings misses recently, and investors are looking for signs of recovery.

Bull Confirmed If

A Q2-2026 EPS of $0.30 or higher would confirm the bull case and suggest a positive trend in profitability.

Bear Confirmed If

An EPS below $0.25 would reinforce the bear case and indicate ongoing challenges in the business.

Pre-Earnings Positioning

Options Market

Implied Move

±8.69%

Historical Avg

±9.1%

In line with history

The options market is pricing in a significant move, indicating that traders expect volatility around the earnings announcement.

Options are pricing ±8.7% while XRAY has averaged ±9.1% over the last 8 prints — setup is roughly in line with history.

Detail

ATM IV

0.5%

30d HV

36.7%

Calls (31K)P/C Ratio: 0.45Puts (11K)

Edge

Historical Setup Match

Cross-company pattern from 30 similar setups.

Prior-quarter miss + options pricing in-line setup in Health Care

n=30

Fade rate: 13 of 29 (45%)

This setup has occurred 30 times across Health Care in the last 2 years. 13 of 29 faded and 16 held — no strong directional bias after the initial reaction. The average absolute 1-day move is 3.6%, with a raw directional average of -1.3% (modestly negative historical bias).

Preparation

Post-Print Playbook

Likely market behavior by outcome — not investment advice.

Beat & Raise

If DENTSPLY SIRONA beats expectations, history suggests a potential stock increase of around 1.5% on the first day, confirming a positive outlook.

In-Line / Cautious

If results are in line with expectations, the stock may see a muted reaction, reflecting ongoing investor caution.

Miss

If the company misses earnings again, history suggests a potential decline of approximately 3.87% on the first day, which could further shake investor confidence.

Earnings Track Record

Preparation

What to Listen For

Call Prep

1Any updates on new product launches and their expected impact on sales.
2Management's commentary on cost management strategies and their effect on gross margins.
3Insights into market demand for dental products and how it may influence future revenue.
4Details on competitive pressures and how the company plans to address them.
5Any guidance on expected revenue growth for the next quarter.

See the full picture

AI-powered briefs, options data, and 20 quarters of history — everything you need before earnings.

No charge today · Auto-bills $8/mo after 7 days · Cancel anytime

More Earnings This Week

5 Reports

Danaos Corporation

Company Snapshot

DENTSPLY SIRONA Inc. (XRAY) is a leading manufacturer of dental products and technologies, operating in the Health Care Supplies sector....

Key Metrics to Watch

Earnings Per Share (EPS)

EPS is a key indicator of the company's profitability and financial health, which investors closely monitor.

N/A

Revenue Growth

Revenue growth reflects the company's ability to expand its market presence and sales, which is vital for long-term success.

N/A

1 more metrics, Wall Street expectations, options signals, track record, and call prep available with Pro.

XRAY Q2-2026 Earnings Preview

Context

Company Snapshot

Earnings Scorecard·Last 8Q

EPS Beat Streak

EPS Beat Rate

38%

Avg EPS Surprise

-1.32%

Avg Stock Reaction

-4.29%

Last Quarter Recap

In Q1-2026, DENTSPLY SIRONA reported an EPS of $0.27, slightly missing estimates. The stock reacted positively, gaining 1.52% the following day.

Management Promises & Guidance

Expectations

Wall Street Expectations

Overall, expectations for DENTSPLY SIRONA's upcoming earnings are cautious, given recent earnings misses. Investors are looking for signs of improvement in profitability and revenue growth.

Bull Case

If DENTSPLY SIRONA can exceed EPS expectations and show strong revenue growth, it could signal a turnaround and boost investor confidence.

Bear Case

Conversely, if the company continues to miss earnings estimates and fails to provide strong guidance, it may lead to further declines in stock price.

Expectations

Two Questions That Matter

The print will turn on these two things.

What will the EPS be for Q2-2026?

EPS is a critical measure of profitability, and a significant deviation from expectations could impact investor sentiment.

How does management plan to address recent revenue growth challenges?

Investors will be keen to hear strategies for improving sales, which is essential for the company's recovery and future growth.

Edge

What the Street Is Missing

Why consensus could be wrong

The market may be underestimating DENTSPLY SIRONA's potential for a turnaround, as recent earnings misses do not fully account for the company's ongoing investments in product innovation.

Supporting Evidence

Options are pricing an 8.69% move, indicating that traders expect significant volatility, which could reflect underlying opportunities.

Despite recent misses, the company's historical performance shows potential for recovery if management can effectively communicate their strategy.

Key Risk

If the EPS comes in above $0.30, it could challenge the bearish sentiment and shift market expectations.

Edge

Thesis-Break Levels

Pre-commit to what would confirm each case.

This quarter's performance is critical as the company has struggled with earnings misses recently, and investors are looking for signs of recovery.

Bull Confirmed If

A Q2-2026 EPS of $0.30 or higher would confirm the bull case and suggest a positive trend in profitability.

Bear Confirmed If

An EPS below $0.25 would reinforce the bear case and indicate ongoing challenges in the business.

Pre-Earnings Positioning

Options Market

Implied Move

±8.69%

Historical Avg

±9.1%

In line with history

The options market is pricing in a significant move, indicating that traders expect volatility around the earnings announcement.

Options are pricing ±8.7% while XRAY has averaged ±9.1% over the last 8 prints — setup is roughly in line with history.

Detail

ATM IV

0.5%

30d HV

36.7%

Calls (31K)P/C Ratio: 0.45Puts (11K)

Edge

Historical Setup Match

Cross-company pattern from 30 similar setups.

Prior-quarter miss + options pricing in-line setup in Health Care

n=30

Fade rate: 13 of 29 (45%)

Preparation

Post-Print Playbook

Likely market behavior by outcome — not investment advice.

Beat & Raise

If DENTSPLY SIRONA beats expectations, history suggests a potential stock increase of around 1.5% on the first day, confirming a positive outlook.

In-Line / Cautious

If results are in line with expectations, the stock may see a muted reaction, reflecting ongoing investor caution.

Miss

If the company misses earnings again, history suggests a potential decline of approximately 3.87% on the first day, which could further shake investor confidence.

Earnings Track Record

Preparation

What to Listen For

Call Prep

1Any updates on new product launches and their expected impact on sales.
2Management's commentary on cost management strategies and their effect on gross margins.
3Insights into market demand for dental products and how it may influence future revenue.
4Details on competitive pressures and how the company plans to address them.
5Any guidance on expected revenue growth for the next quarter.